| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/18/2007 | CN1326842C Electrode-active material and electrodes made by using the same, and cells equipped with the electrodes |
| 07/18/2007 | CN101001860A Heterocyclic antiviral compounds |
| 07/18/2007 | CN100999523A Compound ledebouriella pyrimidine and its separating process |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | US7244845 Silylating a heterocyclic carboxylic acid, then chlorination, then sulfonation, to produce (R)-2-(4'-isopropoxycarbonylaminobiphenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; matrix metalloproteinase inhibitors |
| 07/17/2007 | US7244843 Modulators of serotonin receptors |
| 07/17/2007 | US7244841 Porphyrin derivatives and their use in photodynamic therapy |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/17/2007 | US7244733 N-(4-Chlorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1; angiogenesis inhibitors; anticancer agents; diseases associated with signal transduction pathways operating through growth factor receptors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244729 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur |
| 07/17/2007 | US7244724 Pyrrolobenzodiazepines |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2283018C Package for safe storage of electrophilic fluorinating agent |
| 07/12/2007 | WO2007079470A2 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/12/2007 | WO2007079078A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 07/12/2007 | WO2007078815A2 Certain chemical entities, compositions, and methods |
| 07/12/2007 | WO2007078498A1 Geometric synthesis of porphyrin rods |
| 07/12/2007 | WO2007077766A1 Material for organic electroluminescent device and organic electroluminescent device |
| 07/12/2007 | WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007038459A3 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
| 07/12/2007 | WO2007038314A3 Fused heterocyclic compounds useful as kinase modulators |
| 07/12/2007 | WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 07/12/2007 | WO2007024651A3 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase |
| 07/12/2007 | WO2007019078A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/12/2007 | WO2006029075A3 Fibrate compounds having ppar agonist activity |
| 07/12/2007 | WO2006009718A3 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 07/12/2007 | US20070161790 Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 07/12/2007 | US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161669 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/12/2007 | US20070161667 Process for preparing inhibitors of nucleoside metabolism |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161662 6-Arylmethyl-substituted pyrazolopyrimidines |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161639 Hiv integrase inhibitors |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161632 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 07/12/2007 | US20070161630 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/12/2007 | US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070160871 Material for organic electroluminescent device and organic electroluminescent device |
| 07/12/2007 | US20070160526 Detection, monitoring and treatment of cancer |
| 07/12/2007 | US20070157398 Novel naphthalene derivatives and colorants for keratin fibers containing these compounds |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2635231A1 Protein kinase inhibitors |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1805184A1 Imidazo-benzodiazepine derivatives |
| 07/11/2007 | EP1805183A1 Novel diazabicyclic aryl derivatives and their medical use |
| 07/11/2007 | EP1805182A2 Process for preparing purine compounds |
| 07/11/2007 | EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 07/11/2007 | EP1805150A2 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1805144A1 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1804792A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 07/11/2007 | CN1997646A Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997644A Aryl substituted purine analogues |
| 07/11/2007 | CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/11/2007 | CN1995042A Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses |
| 07/11/2007 | CN1995041A Pyridazineindole derivative and its use |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994301A Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 07/11/2007 | CN1324964C Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 07/10/2007 | US7241892 Hemisynthetic method and new compounds |
| 07/10/2007 | US7241884 Porphines-platinum metal complex compounds for organic electroluminescent device and organic electroluminescent device using them |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241788 Cannabinoid receptor ligands and uses thereof |
| 07/10/2007 | US7241779 Fused pyrrolocarbazoles |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241770 Hydronopol derivatives as agonists on human ORL1 receptors |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241763 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 07/10/2007 | CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 07/05/2007 | WO2007076555A2 A location based wireless collaborative environment with a visual user interface |
| 07/05/2007 | WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | WO2007076127A2 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
| 07/05/2007 | WO2007076086A2 Tricyclic spiro compounds useful as transforming growth factor modulators |
| 07/05/2007 | WO2007076085A2 Fused pyrimidones and thiopyrimidones, and uses thereof |
| 07/05/2007 | WO2007075872A2 Nitroimidazole compounds |
| 07/05/2007 | WO2007075567A1 Triazolopyridazines as tyrosine kinase modulators |
| 07/05/2007 | WO2007075465A1 Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 07/05/2007 | WO2007074340A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |